181 related articles for article (PubMed ID: 32703246)
1. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: statistical analysis plan for a randomised controlled trial (UPGRADE trial).
Haal S; Guman MSS; de Brauw LM; van Veen RN; Schouten R; Fockens P; Gerdes VEA; Dijkgraaf MGW; Voermans RP
Trials; 2020 Jul; 21(1):676. PubMed ID: 32703246
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial.
Haal S; Guman MSS; Boerlage TCC; Acherman YIZ; de Brauw LM; Bruin S; de Castro SMM; van Hooft JE; van de Laar AWJM; Moes DE; Schouten M; Schouten R; van Soest EJ; van Veen RN; de Vries CEE; Fockens P; Dijkgraaf MGW; Gerdes VEA; Voermans RP
Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):993-1001. PubMed ID: 34715031
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial).
Boerlage TCC; Haal S; Maurits de Brauw L; Acherman YIZ; Bruin S; van de Laar AWJM; Moes DE; van Wagensveld BA; de Vries CEE; van Veen R; Schouten R; Dijkgraaf MG; Fockens P; Gerdes VEA; Voermans RP
BMC Gastroenterol; 2017 Dec; 17(1):164. PubMed ID: 29262795
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of ursodeoxycholic acid in preventing new-onset symptomatic gallstone disease after Roux-en-Y gastric bypass surgery.
Haal S; Guman MSS; de Brauw LM; Schouten R; van Veen RN; Fockens P; Gerdes VEA; Voermans RP; Dijkgraaf MGW
Br J Surg; 2022 Oct; 109(11):1116-1123. PubMed ID: 35979609
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with adherence to ursodeoxycholic acid or placebo in patients after bariatric surgery.
Guman MSS; Haal S; Maurits de Brauw L; Hutten BA; Nieuwdorp PM; Nuijen B; Schouten R; van Veen RN; Dijkgraaf PMGW; Voermans RP; Gerdes VEA
Surg Obes Relat Dis; 2022 Jun; 18(6):755-761. PubMed ID: 35387759
[TBL] [Abstract][Full Text] [Related]
6. Increased Incidence of Symptomatic Cholelithiasis After Bariatric Roux-En-Y Gastric Bypass and Previous Bariatric Surgery: a Single Center Experience.
Sneineh MA; Harel L; Elnasasra A; Razin H; Rotmensh A; Moscovici S; Kais H; Shirin H
Obes Surg; 2020 Mar; 30(3):846-850. PubMed ID: 31901127
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Ursodeoxycholic Acid in the Prevention of Cholelithiasis After Sleeve Gastrectomy.
Coupaye M; Calabrese D; Sami O; Siauve N; Ledoux S
Obes Surg; 2019 Aug; 29(8):2464-2469. PubMed ID: 30945151
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic Acid for 6 Months After Bariatric Surgery Is Impacting Gallstone Associated Morbidity in Patients with Preoperative Asymptomatic Gallstones.
Della Penna A; Lange J; Hilbert J; Archid R; Königsrainer A; Quante M
Obes Surg; 2019 Apr; 29(4):1216-1221. PubMed ID: 30604076
[TBL] [Abstract][Full Text] [Related]
9. The Role of Ursodeoxycholic Acid (UDCA) in Cholelithiasis Management After One Anastomosis Gastric Bypass (OAGB) for Morbid Obesity: Results of a Monocentric Randomized Controlled Trial.
Pizza F; D'Antonio D; Lucido FS; Tolone S; Del Genio G; Dell'Isola C; Docimo L; Gambardella C
Obes Surg; 2020 Nov; 30(11):4315-4324. PubMed ID: 32583297
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Symptomatic Gallstone Disease and Gallstone Formation After Bariatric Surgery.
Haal S; Guman MSS; Bruin S; Schouten R; van Veen RN; Fockens P; Dijkgraaf MGW; Hutten BA; Gerdes VEA; Voermans RP
Obes Surg; 2022 Apr; 32(4):1270-1278. PubMed ID: 35143012
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of incidence of cholelithiasis after bariatric surgery in subjects treated or not treated with ursodeoxycholic acid.
Coupaye M; Calabrese D; Sami O; Msika S; Ledoux S
Surg Obes Relat Dis; 2017 Apr; 13(4):681-685. PubMed ID: 28089591
[TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis.
Uy MC; Talingdan-Te MC; Espinosa WZ; Daez ML; Ong JP
Obes Surg; 2008 Dec; 18(12):1532-8. PubMed ID: 18574646
[TBL] [Abstract][Full Text] [Related]
13. The impact of ursodeoxycholic acid on gallstone disease after bariatric surgery: a meta-analysis of randomized control trials.
Fearon NM; Kearns EC; Kennedy CA; Conneely JB; Heneghan HM
Surg Obes Relat Dis; 2022 Jan; 18(1):77-84. PubMed ID: 34772614
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic Acid in the Prevention of Gallstone Formation After Bariatric Surgery: an Updated Systematic Review and Meta-analysis.
Magouliotis DE; Tasiopoulou VS; Svokos AA; Svokos KA; Chatedaki C; Sioka E; Zacharoulis D
Obes Surg; 2017 Nov; 27(11):3021-3030. PubMed ID: 28889240
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials.
Mulliri A; Menahem B; Alves A; Dupont B
J Gastroenterol; 2022 Aug; 57(8):529-539. PubMed ID: 35704084
[TBL] [Abstract][Full Text] [Related]
16. Effect of ursodeoxycholic acid on gallstone formation after bariatric surgery: An updated meta-analysis.
Ying J; Dai S; Fu R; Hong J; Dai C; Jin Q
Obesity (Silver Spring); 2022 Jun; 30(6):1170-1180. PubMed ID: 35475596
[TBL] [Abstract][Full Text] [Related]
17. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study.
Wudel LJ; Wright JK; Debelak JP; Allos TM; Shyr Y; Chapman WC
J Surg Res; 2002 Jan; 102(1):50-6. PubMed ID: 11792152
[TBL] [Abstract][Full Text] [Related]
18. Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve Gastrectomy.
Adams LB; Chang C; Pope J; Kim Y; Liu P; Yates A
Obes Surg; 2016 May; 26(5):990-4. PubMed ID: 26342481
[TBL] [Abstract][Full Text] [Related]
19. The use of Ursolit for gallstone prophylaxis following bariatric surgery: a randomized-controlled trial.
Sakran N; Dar R; Assalia A; Neeman Z; Farraj M; Sherf-Dagan S; Gralnek IM; Hazzan R; Mokary SE; Nevo-Aboody H; Dola T; Kaplan U; Hershko D
Updates Surg; 2020 Dec; 72(4):1125-1133. PubMed ID: 32666477
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Ursodeoxycholic Acid for the Prevention of Gallstone Formation After Gastrectomy in Patients With Gastric Cancer: The PEGASUS-D Randomized Clinical Trial.
Lee SH; Jang DK; Yoo MW; Hwang SH; Ryu SY; Kwon OK; Hur H; Man Yoon H; Eom BW; Ahn HS; Son T; Song KY; Lee HH; Choi MG; An JY; Lee SI; Lee KH; Ahn S; Park YS; Park DJ;
JAMA Surg; 2020 Aug; 155(8):703-711. PubMed ID: 32584935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
